Balochistan Conflict

Showing 239 articles
Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

Olin Corporation: A Tale of Two Valuations as Stock Sends Mixed Signals

Olin Corporation's (NYSE: OLN) stock performance tells a conflicting story: a recent monthly gain contrasts sharply with steep multi-year declines. A deep dive into the numbers reveals a stark divide between cash flow-based and earnings-based valuation models, leaving investors to question where true value lies in the volatile chemicals sector.

Business

Russia's Crypto Mining Giant BitRiver Teeters on the Brink of Bankruptcy

BitRiver, the dominant force in Russia's Bitcoin mining sector, faces a severe financial and legal crisis as court-ordered monitoring of its parent company begins. The turmoil stems from a multi-million dollar contract dispute, regional mining bans, and mounting pressure from sanctions and tax evasion charges against its founder.